Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Mar;8(Suppl 2):S171-S175.
doi: 10.21037/tcr.2019.01.10.

Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?

Stéphane Supiot  1   2 , Caroline Rousseau  2   3
Affiliations
Editorial

Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?

Stéphane Supiot et al. Transl Cancer Res. 2019 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The GETUG P07 trial is an academic sponsored study that received funding from Astellas. The GETUG P13 trial is an academic sponsored study receiving funding from Astra-Zeneca.

Comment on

References

    1. Foster CC, Weichselbaum RR, Pitroda SP. Oligometastatic prostate cancer: Reality or figment of imagination. Cancer 2019;125:340-52. 10.1002/cncr.31860 - DOI - PMC - PubMed
    1. Lecouvet FE, Oprea-Lager DE, Liu Y, et al. Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group. Lancet Oncol 2018;19:e534-45. 10.1016/S1470-2045(18)30571-0 - DOI - PubMed
    1. Fanti S, Minozzi S, Castellucci P, et al. PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data. Eur J Nucl Med Mol Imaging 2016;43:55-69. 10.1007/s00259-015-3202-7 - DOI - PubMed
    1. Ren J, Yuan L, Wen G, et al. The value of anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT in the diagnosis of recurrent prostate carcinoma: a meta-analysis. Acta Radiol 2016;57:487-93. 10.1177/0284185115581541 - DOI - PubMed
    1. Perera M, Papa N, Christidis D, et al. Sensitivity, Specificity, and Predictors of Positive (68)Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926-37. 10.1016/j.eururo.2016.06.021 - DOI - PubMed